What is DeciBio?
DeciBio operates as a specialized consultancy and data analytics powerhouse, focusing exclusively on the precision medicine ecosystem. The firm provides high-fidelity market intelligence, competitive benchmarking, and strategic advisory services that bridge the gap between early-stage research and commercial market entry. By serving a diverse clientele that spans biotech, financial services, and research tools, DeciBio acts as a critical information intermediary. Their methodology integrates rigorous data analytics with deep domain expertise, enabling stakeholders to navigate the complexities of clinical diagnostics and therapeutic development with greater precision and foresight.
How much funding has DeciBio raised?
DeciBio has raised a total of $850K across 2 funding rounds:
Debt
$350K
Debt
$500K
Debt (2020): $350K with participation from PPP
Debt (2024): $500K, investors not publicly disclosed
Key Investors in DeciBio
Undisclosed Investor
An institutional partner providing capital to support the firm's strategic growth initiatives in the precision medicine sector.
PPP
Public-Private Partnership
What's next for DeciBio?
With the recent capital deployment, DeciBio is poised to scale its data-driven service offerings and enhance its proprietary market intelligence platforms. The strategic focus will likely shift toward deepening its footprint in the global biotech and pharma consulting markets, where demand for actionable insights remains high. As the precision medicine sector continues to evolve, DeciBio's ability to synthesize complex market data into strategic roadmaps will be essential for its clients' commercialization efforts. The firm is expected to leverage this financing to bolster its research infrastructure and expand its consulting partnerships, ensuring it remains at the forefront of innovation in the life sciences industry.
See full DeciBio company page
